Glycopyrrolate

Product NDC
76045-023
11-digit product format
760450023
Labeler code
76045
Product ID
76045-023_1925138e-94b7-4e29-815e-f6681943a734
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Glycopyrrolate
Dosage form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Fresenius Kabi USA, LLC
Application
NDA214919
Marketing category
NDA
Marketing start
2022-04-21
Substance
GLYCOPYRROLATE
Active strength
.2 mg/mL
Pharmacologic classes
Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N214919-001GLYCOPYRROLATEGLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-2103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-212680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-215bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-2179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-211e350fbaab3a…
2024-05-31 18:47 UTC2024-05N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-218072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-215c6f7cd8ea54…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-216a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-211c564ffb4f44…
2023-12-20 04:57 UTC2023-12N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-219b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-213f0d92c62455…
2023-05-13 08:27 UTC2023-05N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21053a50430f4f…
2023-01-26 05:58 UTC2023-01N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-213bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-213a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N214919-001GLYCOPYRROLATE0.6MG/3ML (0.2MG/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRLD, RS2022-04-21a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Glycopyrrolate
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GLYCOPYRROLATE.2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
V92SO9WP2IInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2473383Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
685aaf64-1a64-42f9-a96f-4764d650c26fAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
138c3de2-4b03-4255-92b5-f022482d81bcProduct name420260113
4dc252b1-bb5f-8bb6-4fa8-f3a45efd810eProduct name520250304
f58f10d3-5fa9-4c2e-9a6e-77029e9ed80bProduct name120231002
76dcac30-469f-4f92-9c55-70950d209446Product name120230809
132196a6-5117-4b6e-a9dd-27f2793580c6Product name120230112
ac1f888b-a1db-4d2e-abbc-973f21c2ce1bProduct name120220720
d84dd569-7bf0-1410-25eb-017ef37dd406Product name920210902
7d8c8d5a-f174-4e6b-97b1-6fd615c5df9aProduct name120210204
58b12de9-b891-41c7-9be6-ff47de5ec28bProduct name120180828
9aff7b10-8e47-4b10-9a92-803440a37ce2Product name120180206
ce066c73-ca6f-49fc-83d4-d3cf6728e8a1Product name120160616
fb29b8a9-c2d0-42bb-aea8-9bc2a87db75aProduct name120151113
ab7ba50c-5a47-47e6-8dd6-fa32a52559f6Product name120151109
29ae08d1-069f-9822-4820-152d5dc67797Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76045-023-00Glycopyrrolate3 mL in 1 SYRINGEINJECTION37
76045-023-30Glycopyrrolate10 in 1 CARTONINJECTION107

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
76045-023-00ML - Milliliter76045-0237ded261a-cbc0-491e-bad8-ad50fa584aa812022-07-06
76045-023-30ML - Milliliter76045-0234827be5c-6710-4024-9f0a-4d8c774777f312022-07-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76045-023GLYCOPYRROLATE (GLYCOPYRROLATE) INJECTION [FRESENIUS KABI USA, LLC]7Current NDC, Legacy NDC, 2 package rows20240606_685aaf64-1a64-42f9-a96f-4764d650c26f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlycopyrrolateGLYCOPYRROLATEFresenius Kabi USA, LLC685aaf64-1a64-42f9-a96f-4764d650c26f2024-05-14Warnings, Adverse reactionsExact identifier
application applno (NDA): 214919
application number: NDA214919
ndc (product): 76045-023

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2473383glycopyrrolate 0.6 MG in 3 mL Prefilled SyringePSN685aaf64-1a64-42f9-a96f-4764d650c26f7
24733833 ML glycopyrrolate 0.2 MG/ML Prefilled SyringeSCD685aaf64-1a64-42f9-a96f-4764d650c26f7
2473383glycopyrrolate 0.6 MG per 3 ML Prefilled SyringeSY685aaf64-1a64-42f9-a96f-4764d650c26f7

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
76045-023-00760450023003 mL in 1 SYRINGE3 mlHistorical
76045-023-307604500233010 SYRINGE in 1 CARTON (76045-023-30) / 3 mL in 1 SYRINGE (76045-023-00) 10 syringe2022-04-210000-00-00NoNoCurrent